Log in to save to my catalogue

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinoma...

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinoma...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7d0bacc0386448b8808b600af833b466

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?

About this item

Full title

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?

Publisher

New York: Springer US

Journal title

Discover. Oncology, 2023-02, Vol.14 (1), p.21-21, Article 21

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Aim
To assess whether serum thymidine kinase 1 (STK1p), CEA and CA19.9 can be used as prognostic biomarkers in the primary tumor location (PTL) of colorectal carcinoma (CRC). Additional clinical factors of TNM stage, pathological grade, age and sex were also included.
Methods
STK1p was determined by an ECL-dot-blot assay, and CEA/CA19.9 wa...

Alternative Titles

Full title

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7d0bacc0386448b8808b600af833b466

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7d0bacc0386448b8808b600af833b466

Other Identifiers

ISSN

2730-6011

E-ISSN

2730-6011

DOI

10.1007/s12672-023-00614-5

How to access this item